Eccentric Exercise Training as Novel Rehabilitation for Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive Clinical Trial

Official title:

Eccentric Training as Novel Rehabilitation for COPD

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01077102
• Other study ID #: MUHC Pilot Project 2007
• Status: Completed
• Phase: N/A
• Start date: January 2011
• Est. completion date: December 2012

Study information

• Verified date: August 2018
• Source: McGill University Health Center
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The main purpose of this project is to establish the additional value of eccentric versus concentric exercise to optimize muscle function in patients with severe COPD. With this pilot project the investigators expect that an eccentric endurance training protocol adapted to severe COPD patients will lead to gains in muscle strength, the primary outcome, and cellular adaptation (muscle morphology and oxidative capacity, mitochondrial respiratory capacity) when compared to a concentric training approach.

This information will be essential if the investigators want to design and power a randomized clinical trial that will allow assessing effectiveness of this novel rehabilitation approach.

Description:

Chronic obstructive pulmonary disease (COPD) is a major respiratory illness that is both preventable and treatable. Dyspnea is the most important symptom that COPD patients experience and this can have a major impact on their daily live. While COPD is characterized by a spectrum of disease severity, most patients experience poor exercise intolerance attributable to ventilatory limitation as well as peripheral muscle fatigue, ultimately leading to severe disability.

Endurance exercise is an important component of pulmonary rehabilitation and is aimed at preventing this decline in functional capacity. The effects of pulmonary rehabilitation are largely attributable to the exercise training component involving concentric muscle contractions, traditionally trough dynamic, large muscle exercise on a cycle ergometer or treadmill. However, many patients are unable to partake and benefit from such rehabilitation because of locomotor muscle weakness and severe ventilatory limitation that prevent them from exercising at intensities sufficient to provoke improvements in cardioventilatory and skeletal muscle function. Eccentric exercise is known for its unique physiologically fundamental characteristics: the lower metabolic demand for a same power output and greater muscle gains compared to the concentric exercise. For this reason, eccentric endurance training has been proposed as a novel adjunctive rehabilitative countermeasure for certain chronic diseases (such as coronary disease and COPD) and can play an important role for patients with advanced disease.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 24
• Est. completion date: December 2012
• Est. primary completion date: December 2012
• Accepts healthy volunteers: No
• Gender: Male
• Age group: 40 Years to 80 Years

Eligibility

Inclusion Criteria:

• male patients with severe COPD (FEV1/FVC < 0.70 and FEV1 = 50% predicted of normal)

• Patients aged 40 to 80 years old in whom exercise is not contraindicated

• Current and ex-smokers

• Patients who do not require oxygen therapy

Exclusion Criteria:

• Patients presenting neurological or orthopedic problems, morbid obesity, acute medical condition or recent exacerbations (in the last four weeks)

• Patients with recent or current participation in a rehabilitation program

Related Conditions & MeSH terms

• Bronchitis
• Bronchitis, Chronic
• Chronic Disease
• Emphysema
• Lung Diseases
• Pulmonary Disease, Chronic Obstructive

Intervention

Other:
• Eccentric exercise training
The eccentric exercise training will be performed using a specially built cycle ergo meter where the pedals are driven in backward direction by an electric motor, which has to overcome the adjustable resistance of the electromagnetic brake. During eccentric cycle ergometry patients have to resist the turning pedals.

Locations

Country	Name	City	State
Canada	Montreal Chest Institute	Montreal	Quebec

Sponsors (1)

Lead Sponsor	Collaborator
McGill University Health Center

Country where clinical trial is conducted

Canada, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Muscle strength	This outcome will be measured using an isokinetic dynamometer	At baseline, at the middle way point of the training program (5th to 7th week) and at the end of the 10-wk training program
Secondary	Muscle cellular adaptation	Muscle biopsy will include evaluation of cross-sectional area, fiber type, mitochondrial oxidative capacity, mitochondrial respiratory capacity, respiratory oxygen species and expression of genes involved in muscle atrophy and hypertrophy (Atrogin-1, MurF1, FoxO, MyoD, Myostatin)	At baseline and at the end of the training program
Secondary	Exercise capacity (maximal and submaximal)		At baseline, at the middle way point of the training program (5th to 7th week) and at the end of the 10-wk training program
Secondary	Physical Activity	Physical activity levels will be measured by an accelerometer and by the CHAMPS questionnaire.	At baseline, at the middle way point of the training program (5th to 7th week) and at the end of the 10-wk training program
Secondary	Health-related quality of life (HRQL)	The HRQL will be measured by the Chronic Respiratory Questionnaire	At baseline, at the middle way point of the training program (5th to 7th week) and at the end of the 10-wk training program
Secondary	Muscle pain and creatine kinase(CK)levels		Muslce pain will be assessed in the beginning and in the end of each session and CK levels at baseline, after the fisrt week of training, midway through and the after the last week of training